JSLL Publishes Case Studies Validating Ayurvedic Treatments for Liver Disorders, Infertility & Diabetes
The scientific validation of its treatments through published case studies can significantly boost the company's reputation, increase patient trust, and potentially drive business growth by demonstrating the efficacy of its healthcare solutions.
The publication of scientific case studies provides strong evidence of the effectiveness of JSLL's Ayurvedic treatments, enhancing its credibility and validating its core business offerings.
* Jeena Sikho Lifecare Limited (JSLL) announced on 28 August 2025, the publication of four case studies in "AYUSHDHARA - An International Journal of Research in AYUSH and Allied Systems" (May-June 2025 issue, published on 25 July 2025). * These studies, co-authored by medical professionals associated with JSLL, including Managing Director Acharya Manish Grover Ji, highlight the company's dedication to advancing Ayurvedic research and promoting evidence-based clinical practices. * The published case studies cover a range of conditions: * "Approach of Ayurvedic Management Towards Restoration of Liver Health in Hepatomegaly with Fatty Liver: A Case Study Referring to Yakrit Vriddhi" * "Management of Tubal Blockage Through Ayurveda: A Clinical Case Study" * "Enlightening on Effectual Ayurvedic Therapeutics in Early Diagnosed Type 2 Diabetes Mellitus" * "Influential Effect of Diet and Panchakarma Therapy in Liver Disease: A Case Study Especially Referencing to the Vataja Yakrita Vikara" * The liver health case study demonstrated significant success, with a 53-year-old male patient's hepatomegaly and fatty liver normalizing within 3 months and renal issues improving by the 4th month, through Ayurvedic formulations and lifestyle modifications (DIP diet, exercise). * The company emphasized that the findings underscore the efficacy of integrated Ayurvedic treatment and lifestyle management in reversing lifestyle-induced disorders without side effects and preventing recurrence.
What to do with a filing like this
Jeena Sikho Lifecare Limited filed this with the NSE as a statutory disclosure, categorised under press release. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Jeena Sikho Lifecare Limited. Read the original for the full detail.